CN108936628A - A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible - Google Patents
A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible Download PDFInfo
- Publication number
- CN108936628A CN108936628A CN201810883264.4A CN201810883264A CN108936628A CN 108936628 A CN108936628 A CN 108936628A CN 201810883264 A CN201810883264 A CN 201810883264A CN 108936628 A CN108936628 A CN 108936628A
- Authority
- CN
- China
- Prior art keywords
- parts
- lactobacillus
- bifidobacterium
- acid
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 43
- 230000002490 cerebral effect Effects 0.000 title claims abstract description 43
- 208000006011 Stroke Diseases 0.000 title claims abstract description 42
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 49
- 235000013305 food Nutrition 0.000 claims abstract description 41
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 38
- 239000006041 probiotic Substances 0.000 claims abstract description 34
- 235000018291 probiotics Nutrition 0.000 claims abstract description 34
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 29
- 239000011707 mineral Substances 0.000 claims abstract description 29
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 23
- 150000001413 amino acids Chemical class 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 36
- 229940024606 amino acid Drugs 0.000 claims description 24
- 235000001014 amino acid Nutrition 0.000 claims description 24
- 241000186660 Lactobacillus Species 0.000 claims description 20
- 229940039696 lactobacillus Drugs 0.000 claims description 20
- 238000010348 incorporation Methods 0.000 claims description 19
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 18
- 241000894006 Bacteria Species 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 16
- -1 compound amino acid Chemical class 0.000 claims description 16
- 235000018102 proteins Nutrition 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 241000186000 Bifidobacterium Species 0.000 claims description 15
- 229940088598 enzyme Drugs 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 229940088594 vitamin Drugs 0.000 claims description 15
- 239000011782 vitamin Substances 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- 244000197580 Poria cocos Species 0.000 claims description 14
- 235000008599 Poria cocos Nutrition 0.000 claims description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- 241001264174 Cordyceps militaris Species 0.000 claims description 12
- 240000004371 Panax ginseng Species 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 12
- 235000013399 edible fruits Nutrition 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 241000304531 Allium macrostemon Species 0.000 claims description 11
- 240000001008 Dimocarpus longan Species 0.000 claims description 11
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 11
- 244000119298 Emblica officinalis Species 0.000 claims description 11
- 235000015489 Emblica officinalis Nutrition 0.000 claims description 11
- 235000000235 Euphoria longan Nutrition 0.000 claims description 11
- 241001558017 Gynura Species 0.000 claims description 11
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 11
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 11
- 244000131360 Morinda citrifolia Species 0.000 claims description 11
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 11
- 235000004347 Perilla Nutrition 0.000 claims description 11
- 244000124853 Perilla frutescens Species 0.000 claims description 11
- 241000233805 Phoenix Species 0.000 claims description 11
- 244000046146 Pueraria lobata Species 0.000 claims description 11
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 11
- 239000009759 San-Chi Substances 0.000 claims description 11
- 241001145025 Saussurea involucrata Species 0.000 claims description 11
- 230000035622 drinking Effects 0.000 claims description 11
- 235000008216 herbs Nutrition 0.000 claims description 11
- 230000010354 integration Effects 0.000 claims description 11
- 235000017524 noni Nutrition 0.000 claims description 11
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 10
- 244000144730 Amygdalus persica Species 0.000 claims description 10
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 10
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 10
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 10
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 10
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 10
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 10
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 10
- 240000000171 Crataegus monogyna Species 0.000 claims description 10
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 10
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 10
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 10
- 241000208688 Eucommia Species 0.000 claims description 10
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 10
- 235000013325 dietary fiber Nutrition 0.000 claims description 10
- 239000001702 nutmeg Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 9
- 240000001579 Cirsium arvense Species 0.000 claims description 9
- 235000005918 Cirsium arvense Nutrition 0.000 claims description 9
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 9
- 229940108924 conjugated linoleic acid Drugs 0.000 claims description 9
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 9
- 229960004488 linolenic acid Drugs 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 241000168517 Haematococcus lacustris Species 0.000 claims description 8
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 8
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 8
- 235000019198 oils Nutrition 0.000 claims description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 8
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 7
- 229930182816 L-glutamine Natural products 0.000 claims description 7
- 108090000526 Papain Proteins 0.000 claims description 7
- 239000004365 Protease Substances 0.000 claims description 7
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 229940055729 papain Drugs 0.000 claims description 7
- 235000019834 papain Nutrition 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- 239000004382 Amylase Substances 0.000 claims description 6
- 102000013142 Amylases Human genes 0.000 claims description 6
- 108010065511 Amylases Proteins 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 235000019418 amylase Nutrition 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 5
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 5
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 5
- 241000186012 Bifidobacterium breve Species 0.000 claims description 5
- 241001608472 Bifidobacterium longum Species 0.000 claims description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 5
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 5
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 5
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 5
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 5
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 5
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 5
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 5
- 108010038807 Oligopeptides Proteins 0.000 claims description 5
- 102000015636 Oligopeptides Human genes 0.000 claims description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 5
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 5
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 5
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 5
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 5
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 5
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 5
- 229930182817 methionine Natural products 0.000 claims description 5
- 229920001542 oligosaccharide Polymers 0.000 claims description 5
- 150000002482 oligosaccharides Chemical class 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 238000009928 pasteurization Methods 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 4
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 4
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 4
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- 235000019483 Peanut oil Nutrition 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- 108010073771 Soybean Proteins Proteins 0.000 claims description 4
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 4
- 235000019486 Sunflower oil Nutrition 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 4
- 210000000988 bone and bone Anatomy 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- 235000005687 corn oil Nutrition 0.000 claims description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 4
- 229960000310 isoleucine Drugs 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 4
- 239000000944 linseed oil Substances 0.000 claims description 4
- 235000021388 linseed oil Nutrition 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 210000001161 mammalian embryo Anatomy 0.000 claims description 4
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 4
- 239000000312 peanut oil Substances 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 239000003549 soybean oil Substances 0.000 claims description 4
- 235000012424 soybean oil Nutrition 0.000 claims description 4
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 4
- 239000002600 sunflower oil Substances 0.000 claims description 4
- 229960003080 taurine Drugs 0.000 claims description 4
- 229940026510 theanine Drugs 0.000 claims description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 108010046377 Whey Proteins Proteins 0.000 claims description 3
- 240000008866 Ziziphus nummularia Species 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 229910052804 chromium Inorganic materials 0.000 claims description 3
- 239000011651 chromium Substances 0.000 claims description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 229910052750 molybdenum Inorganic materials 0.000 claims description 3
- 239000011733 molybdenum Substances 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 229960003104 ornithine Drugs 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011772 phylloquinone Substances 0.000 claims description 3
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 235000019710 soybean protein Nutrition 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 235000021119 whey protein Nutrition 0.000 claims description 3
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 240000005809 Prunus persica Species 0.000 claims description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 244000170916 Paeonia officinalis Species 0.000 claims 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims 2
- 244000270834 Myristica fragrans Species 0.000 claims 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims 1
- 241000220287 Sedum rubrotinctum Species 0.000 claims 1
- 235000019742 Vitamins premix Nutrition 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- 210000004681 ovum Anatomy 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 21
- 230000035764 nutrition Effects 0.000 abstract description 21
- 239000000284 extract Substances 0.000 abstract description 19
- 150000001720 carbohydrates Chemical class 0.000 abstract description 14
- 230000036039 immunity Effects 0.000 abstract description 14
- 210000004185 liver Anatomy 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 10
- 239000002994 raw material Substances 0.000 abstract description 8
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 210000002784 stomach Anatomy 0.000 abstract description 7
- 210000000936 intestine Anatomy 0.000 abstract description 6
- 238000011160 research Methods 0.000 abstract description 5
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract description 3
- 230000006907 apoptotic process Effects 0.000 abstract description 2
- 210000002569 neuron Anatomy 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 19
- 235000019197 fats Nutrition 0.000 description 18
- 230000006870 function Effects 0.000 description 17
- 230000000968 intestinal effect Effects 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 230000009102 absorption Effects 0.000 description 13
- 238000010521 absorption reaction Methods 0.000 description 13
- 235000014633 carbohydrates Nutrition 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 10
- 229930003231 vitamin Natural products 0.000 description 9
- 235000013343 vitamin Nutrition 0.000 description 9
- 150000003722 vitamin derivatives Chemical class 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 241000498779 Myristica Species 0.000 description 8
- 241000736199 Paeonia Species 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000007071 enzymatic hydrolysis Effects 0.000 description 6
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- 206010008092 Cerebral artery thrombosis Diseases 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229940106157 cellulase Drugs 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000008344 brain blood flow Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 231100000481 chemical toxicant Toxicity 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 150000002632 lipids Chemical group 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical group C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000003241 Fat Embolism Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 208000035211 Heart Murmurs Diseases 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020575 Hyperammonaemia Diseases 0.000 description 1
- 206010020674 Hypermetabolism Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 229930189077 Rifamycin Natural products 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 241001591005 Siga Species 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000000569 greater omentum Anatomy 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000027700 hepatic dysfunction Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000008085 high protein diet Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 229960003292 rifamycin Drugs 0.000 description 1
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 description 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 1
- 229960003040 rifaximin Drugs 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 210000002385 vertebral artery Anatomy 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses the specific full nutritional formulas that a kind of patients with cerebral apoplexy is eaten.The formula is according to the requirement of " special medicine purposes formula food general rule ", in conjunction with the constitutive character of patients with cerebral apoplexy, the research achievements such as advanced physiology, medicine, nutrition and the clinical application of comprehensive nowadays American Harvard University, the marrow of the Traditional Chinese Medicine according to " middle residence that disappears is mended ", " balanced tone " theoretical (the dirty people having the same aspiration and interest of liver,spleen,kidney three is main principle) develop.The product uses the Chinese medical extract essence of a variety of dual-purpose of drug and food, a variety of probiotics, small peptide for primary raw material, mixes using prebiotics, carbohydrate, amino acid, fatty powder, multivitamin and minerals as auxiliary material.In addition, a kind of preparation method of the specific full nutritional formulas eaten the present invention also provides patients with cerebral apoplexy.It can be used as the nutritional need that single source of nutrition meets patients with cerebral apoplexy, also act and inhibit nerve cell apoptosis, improve immunity and adjust the function of stomach and intestine.
Description
Technical field
The invention belongs to integration of drinking and medicinal herbs class formula and food processing technology fields, specifically by " Chinese medicine of integration of drinking and medicinal herbs "
Traditional Chinese Medicine marrow theory and " multiple probiotics " combine, and add with albumen small peptide, prebiotics, amino acid, carbon water
Compound, fat, multi-vitamins, composite mineral matter are cerebral apoplexy full nutrition formula food and its preparation side made of auxiliary material
Method.
Background technique
Cerebral apoplexy (cerebral apoplexy) is a kind of brain blood circulation disorder disease of unexpected onset, is shown as
Cerebral ischemic and heamorrhagic lesions have high case fatality rate and disability rate.Cerebral apoplexy is broadly divided into hemorrhagic apoplexy (brain
Bleeding or subarachnoid hemorrhage) and cerebral arterial thrombosis (cerebral infarction, cerebral thrombosis) two major classes, wherein cerebral arterial thrombosis
(ischemic stroke) accounts for the 86% of whole cerebral apoplexies.Cerebral apoplexy be endanger middle-aged and the old's health principal disease it
One, it is commonly encountered diseases of internal department, frequently-occurring disease.Cerebral apoplexy every annual morbidity in China's is 0.219%, disability rate 75.0%;
When cerebral arterial thrombosis, angiemphraxis can occur in any artery for arriving brain.Such as the deposition of lipid can occur
In arteria carotis, so that so that blood flow is attenuated such as the pipeline of obstacle as water flow by one, this situation is quite serious, because of every side
Arteria carotis usually provides most brain blood supply, and lipid can also fall off from carotid wall, with blood flow, blocks petty action
Arteries and veins, being finally allowed to block arteria carotis, vertebral artery and its branch completely can be caused to block by other reasons.Such as in heart and heart valve
The thrombus breaks loose that film is formed, with artery blood flow to brain, its result causes embolic cerebral apoplexy, and the cerebral apoplexy of this type is most common
In receiving cardiac operation recently, have the patient of cardiac valve lesion and arrhythmia cordis, fat embolism is the rare original of cerebral apoplexy
Cause will form many embolus brain blood if the fat from fracture site marrow enters blood flow and finally merges in intra-arterial
Pipe is narrow because of inflammation or infection to may also lead to cerebral apoplexy, and the drugs such as cocaine and amphetamine can also make hemadostewnosis to lead
Cerebral apoplexy is caused, blood pressure decline suddenly often seriously reduces brain blood flow, causes to faint, if low blood pressure seriously and continues in the presence of can also
Massive blood loss, myocardial infarction or heart murmur caused by causing cerebral apoplexy, this situation that can betide wound and perform the operation;
For food of special nutrients, there are corresponding regulation and development and application in developed countries such as the U.S., European Union;And China
Wholefood clear stipulaties in GB29922-2013 " special medicine purposes formula food general rule " national food safety standard:
2.1.1 full nutrition formula food: it can be used as the special medicine purposes formula that single source of nutrition meets target group's nutritional need
Food;2.1.2 specific full nutritional formulas: it can be used as single source of nutrition and meet target group in specified disease or medicine shape
The special medicine purposes formula food of nutritional need under condition;
Traditional Chinese medicine thinks: " spleen (i.e. digestive system) is the foundation of acquired constitution ", stomach health are health sheets, human nutrition
99% needs by intestinal absorption, and intestinal bowel disease is also source of ten thousand diseases;But with age, profitable strain (probiotics) in enteron aisle
Ratio gradually decreases;If Bifidobacterium Bifidum accounts for 98% in infant period, 5% is only accounted for after 10%, 65 years old is down to when to the middle age;People gets over
Always, probiotics is fewer, and function of intestinal canal is also gradually reduced therewith, more and more studies have shown that normal floras in human consumption, exempt from
Epidemic disease and disease-resistant etc. there are many irreplaceable roles;The change and a variety of diseases, especially enteron aisle disease of intestinal flora composition
The occurrence and development of disease are closely related, and find from existing clinical research: probiotics can play adjusting intestinal flora, control enteritis
Disease effect is that one kind safely and effectively intervenes adjusting method;
The relationship of Dysbiosis and cerebral apoplexy: being in high de-agglomeration hypermetabolism symptom, at body for cerebral apoplexy Cavity in Critical Patients more
In negative nitrogen balance state, intestinal microecology balance is destroyed, and obstacle, Jin Erying occurs in easy damaged gut barrier, gastrointestinal function
Patient clinical treatment and prognosis are rung, may result in enterogenic infection.Probiotics can be by improving mucous membrane surface microorganism
Flora achievees the purpose that stimulate immunity of organism mechanism, and then promotes immunity of organisms, especially Bacillus acidi lactici, and main includes planting
Object lactobacillus, bifidobacterium breve, bifidobacterium longum etc. adjust intestinal flora composition.Though direct probiotic oral has certain effect,
But since probiotics can not be colonized in enteron aisle, and stop, occupy-place it is seldom, be easy to run off, it is easy to recur to withdraw rear harmful bacteria, related
Patient needs to take for a long time, and treatment cycle is long, often very high using rear recurrence rate;For shorten associated patient treatment cycle,
Recurrence rate after being discontinued is reduced, this seminar is studied by being colonized the key technology of mechanism over nearly 3 years in enteron aisle to probiotics,
Make great efforts to seek to improve " Chinese medicine of integration of drinking and medicinal herbs " compound that probiotics is colonized in enteron aisle, it is contemplated that probiotics is colonized in enteron aisle
Several key elements: the presence of prebiotics can play field planting effect, intestinal pH environment reduction and improve probiotic cell
Enteron aisle adhesive capacity etc. is based on above-mentioned element, and suitable food materials screen from tens of kinds " Chinese medicine of integration of drinking and medicinal herbs " in this seminar,
Prebiotics are added, after L-Glutamine etc., have very strong field planting effect to external source probio, are benefit in enteral microecological formulation
The prescription selection of raw bacterium provides experimental basis;
At present favorably to the middle medicinal substances and short skin, compound protein, unsaturated fatty acid, a variety of ammonia in integration of drinking and medicinal herbs
Base acid, vitamin and mineral combine the manufactured medicine formula food for being used for patients with cerebral apoplexy rehabilitation;There are also multiple using Chinese medicine
Side is the product of primary raw material;The constitutive character that patients with cerebral apoplexy is combined but without discovery, the marrow according to Traditional Chinese Medicine are managed
By varying with each individual, gold compatibility is with the Chinese medical extract essence of more than ten kinds of dual-purpose of drug and food, a variety of probiotics, protein, small peptide
Primary raw material, using prebiotics, carbohydrate, amino acid, fat, multivitamin and several mineral materials to be complete made of auxiliary material
Nutritional formulas, specific full nutritional formulas or similar products.
Summary of the invention
It is initiative by a variety of raising patients with cerebral apoplexy the purpose of the present invention is on inheriting Chinese medicine marrow theory treatment method
The probiotics of immunity and the extract of " Chinese medicine of integration of drinking and medicinal herbs " compound combine, add with albumen small peptide, ammonia
Base acid, carbohydrate, fat, multivitamin, several mineral materials are auxiliary material, and it is required can not only to supplement patients with cerebral apoplexy institute
Nutrient improves body nutrition condition, moreover it is possible to adjust body function, probiotics using the function factor in dual-purpose of drug and food Chinese herbal medicine
Adjusting intestinal flora can be played, toxic side effect is small, safe and effective, and the spy that the acceptable suitable patients with cerebral apoplexy of people is edible
Determine full nutrition formula food and preparation method thereof.
The requirement of this R&D team basis " special medicine purposes formula food general rule ", the constitution in conjunction with patients with cerebral apoplexy are special
Sign, the research achievements such as advanced physiology, medicine, nutrition and the clinical application of comprehensive nowadays American Harvard University, according to " in disappearing
The marrow of the Traditional Chinese Medicine of residence benefit ", " balanced tone " is theoretical (the dirty people having the same aspiration and interest of liver,spleen,kidney three is main principle), uses 10 kinds to add medicine to
Eat it is dual-purpose extract obtain extract essence, a variety of probiotics, albumen small peptide be primary raw material, with prebiotics, carbohydrate,
Amino acid, fat, multivitamin and minerals auxiliary material, take specific preparation process, are uniformly mixed and powderous preparations are made, no
It only can be used as the nutritional need that single source of nutrition meets patients with cerebral apoplexy, there are also benefiting qi and nourishing blood, inhibition nerve cell apoptosis, mention
The full nutrition formula food of high immunity and the function of adjusting stomach and intestine, specific full nutritional formulas or non-full nutrient formulation food
Product;
1, the extract component of inventive formulation
Integration of drinking and medicinal herbs extract is to be adjusted to together according to the constitutive character of patients with cerebral apoplexy from the liver,spleen,kidney three in theory of traditional Chinese medical science is dirty
Main principle adjusts body function using the function factor in dual-purpose of drug and food Chinese herbal medicine and builds up resistance, and chooses following several major class
Drug carries out compatibility;Wherein: Cordyceps militaris enters lung kidney two warp, can tonifying lung yin and kidney-replenishing, cure mainly kidney deficiency, impotence and seminal emission, waist
Knee joint soreness, eak after being ill, chronic cough is weak, phthisical cough phlegm blood, spontaneous sweating etc..Ginseng can reinforce vital energy, veins takes off admittedly, tonifying spleen benefit
Lung, shengjin nourishing, tranquilize the mind and promote the intelligence.Rhizoma polygonati is sweet in flavor mild-natured, can boosting qi and nourishing yin, invigorating the spleen, moistening lung, kidney-nourishing.Fructus lycii is sweet in flavor, mild-natured,
Nourishing the liver, nourshing kidney, moistening lung cure mainly caused by liver and kidney deficiency, have a dizzy spell, is visually unclear, soreness and weakness of waist and knees.Poria cocos medicinal peace, contained Poria cocos
Acid has the function of strengthen immunity, antitumor and calm, hypoglycemic etc..Semen ziziphi spinosae is sweet in flavor acid flat, can nourishing heart tonifying liver, peaceful
Heart and tranquilizing mind, promotes the production of body fluid at arrest sweating.It is thin to nourish brain containing unsaturated fatty acid necessary to more protein and human nutrition for walnut kernel
Born of the same parents enhance brain function;
Chinese medical extract of the present invention refers to Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), Cordyceps militaris, fructus alpiniae oxyphyllae, arillus longan, Noni fruit, acid
It is jujube kernel, dried orange peel, rhizoma polygonati, pueraria lobata, fructus lycii, peach kernel, phoenix peony, Poria cocos, purple perilla seed, nutmeg, emblic, hawthorn, small
Ji, Longstamen Onion Bulb, rhizoma imperatae, sea-buckthorn, eucommia Bark male flower, sanchi flower, Chinese yam, ginseng (artificial growth), 10 kinds therein of Saussurea involucrata culture
Above or all, by the way that cellulase, pectase, papain and starch are added after the 60min-100min that is soaked in water
Enzyme, 1 mg/g substrate of enzyme dosage, pH value is 4.0-5.0, in 50-80 DEG C of enzymatic hydrolysis 1-3h, solid-liquid ratio 1:15, with biological enzyme
After solution technology extracts Chinese medicine essence, extraction mixture that is spray-dried and being prepared into flour;
2, a variety of probiotics
So that probiotics is largely reached enteron aisle by the strong acid environment of stomach, to promote the proliferation of probiotics, adjusts the micro- life of enteral
State balance, promotes the absorption to microelement, enhances taste motor function, accelerates the absorption of drug effect, improve the micro- of mucous membrane surface
The balance of biota or enzyme, or stimulation body specificity or nonspecific immunity mechanism, improve body colonization resistance or immunity;
Xing etc. pre-processes law during ischemia/reperfusion rat with Bifidobacterium and Bacillus acidi lactici, can be substantially reduced intestinal endotoxemia
Horizontal and preventing liver injury generation;Selective enteron aisle decontamination dye is also the important measures of adjustment intestinal microecology, there is research
It does not absorb that rifamycin antibiotic former times is bright (rifaximin) using enteron aisle, passes through the life for inhibiting urease-producing in enteron aisle and producing ammonium bacteria
It is long, to build up resistance;
A variety of probiotics of the present invention all use the probiotics after microencapsulation, in addition to streptococcus thermophilus, wherein bifid
Bacillus: refer to bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, bifidobacterium breve, bifidobacterium infantis, long bifid
Bacillus is one of, several or whole mixes;Lactobacillus refers to: lactobacillus acidophilus powder, Lactobacillus casei, bulgarian milk bar
Bacterium, Lactobacillus delbrueckii, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, Lactobacillus salivarius, Lactobacillus rhamnosus,
Lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus are one of, several or whole mixes;
3, albumen small peptide
Small peptide is oligopeptide, refers to small point of one kind of the separation and Extraction from animal or vegetable protein using bio-enzyme engineering technology
Sub- protein, average molecular weight in 1000Dalton hereinafter, soluble easily in water, to acid, thermostabilization, can be not required to by digestion and
It directly absorbs, bioavailability is high, is absorbing and using upper better than free amino acid and complete protein, can be applied to egg
In white matter supplement, particularly with the low crowd of abilities of digestive and absorption, small peptide is splendid nitrogen source, in addition to trophic function,
Small peptide also has a series of physiological active functions: the digestion and absorption function of small intestine improved, immunity of organisms is enhanced, it is anti-oxidant,
Auxiliary adjustment blood glucose, auxiliary adjustment of blood fat, aided blood pressure-lowering is anti-radiation, promotes mineral absorption, enhances dual-purpose of drug and food medium-height grass
The function and effect of function factor in medicine;
Albumen small peptide of the present invention refer to ocean fish oligopeptide, dragon protein, sea bone peptide, soybean protein, whey egg
White peptide, ovalbumin peptide are one of, several or whole mixes;
4, prebiotics
To promote probiotics intestinal colonisation, enteron aisle convergence, reduce intestinal pH environment, also do not utilized by most of enteron aisle spoilage organisms,
But beneficial bacteria in human body can be promoted --- lactobacillus, Bifidobacterium growth and breeding, so as to inhibit spoilage organisms to grow,
Help to improve and maintain enteron aisle normal function;Long-term consumption can delay aging, defaecation, improve immunity, mitigation liver is born
Load, the absorptivity for improving nutrient, can especially improve body to Metal Ions Absorptions such as calcium, iron, zinc;Optionally promote
Into outside the growth and breeding of beneficial bacterium (bifid, lactic acid), also metabolizable is the organic acids such as acid product such as lactic acid, makes colon pH
Value reduces, and inhibits the growth of intestinal harmful bacillus;So that small enteral Water-Electrolyte is trapped in enteric cavity, generate height and ooze effect, stimulates intestines
Wriggling causes laxative, to promote intestinal endotoxin and the discharge of other toxicants, lactulose can also be inactivated directly in enteron aisle
Endotoxin reduces gut pH, has been widely applied to the treatment of enhancing child resistant;
Prebiotics of the present invention are 2 classes
A. there are very strong field planting effect prebiotics: fructus lycii, ginseng, Poria cocos, the extract of jerusalem artichoke, wood to external source probio
Sugar, yeast are therein several or all mix;
B. common prebiotics: oligoisomaltose, oligofructose, soyabean oligosaccharides, xylo-oligosaccharide are one such, several or complete
Portion's mixing;
The present invention refers to that oligoisomaltose, stachyose, oligofructose, soyabean oligosaccharides, xylo-oligosaccharide are one such, several
Or all mixing;
5, carbohydrate
Carbohydrate is made of three kinds of carbon, hydrogen and oxygen elements, it is that three kinds of main nutrition of thermal energy are provided for human body
Most cheap nutrient in element, when intake is sufficient, in vivo can rapid oxidation energy is provided in time, avoid valuable protein
For providing energy, carbohydrate be also the glycoprotein of cell membrane, nerve fiber glycolipid and convey hereditary information de-
The important composition ingredient of oxygen ribonucleic acid (DNA), and the glycogen contained in carbohydrate, when it lays in abundance in liver
When, the toxin that liver cell generates certain toxic chemical substances and various pathogenic microorganisms has stronger detoxification ability;
Carbohydrate of the present invention refers to glucose, fructose, galactolipin, lactose, L-arabinose, maltose, water-soluble
Property dietary fiber, starch, glycogen be one such, several or all mixing;
6. amino acid
It is divided into essential amino acid and nonessential amino acid, is the basic unit for constituting protein, assigns the specific molecule of protein
Structural form makes it have biochemical activity;Absorbing suitable methionine facilitates the metabolism of various sulfur-containing compounds in human body simultaneously
And the methyl contained by it methylates to Toxic or drug and plays the role of removing toxic substances;Leucine can repair muscle, control
Blood glucose processed, and energy is provided to bodily tissue, it is necessary to amino acid phenylalanine can inhibit cancer growth, and can reduce drug
Toxic side effect, lysine can be improved the absorption and utilization of food protein, reaches balanced nutritious, enhancing development;Smart ammonia
Acid helps the ammonia in blood being changed into urea and excrete out;For hyperammonemia, hepatic dysfunction etc. is powerful;
Histidine reduces gastric acidity, mitigates the pain of gastrointestinal procedures, mitigates gestational period vomiting and scorching hot sense, inhibits by plant mind
It festers through alimentary canal caused by anxiety, it is also powerful to anaphylactia, such as asthma;Tryptophan can prevent pellagra,
Depression improves sleep and adjusts mood;
Amino acid of the present invention refer to L-Glutamine, methionine, isoleucine, tyrosine, phenylalanine, lysine,
Arginine, histidine, tryptophan, citrulling, ornithine, taurine, γ-aminobutyric acid, tealeaves theanine are one such, several
Kind or all mixing;
7. fatty powder
Fat is commonly called as grease, is made of carbon, hydrogen and oxygen element;It is both important composition part and the heat of tissue
One of main matter of amount;Fat in food digests in stomach, most of after absorption to be changed into fat once again again;It is main
Be distributed in around subcutis, omentum majus, mesenterium and kidney etc.;The trigalloyl that fat is made of glycerol and fatty acid
Glyceride, wherein the molecule of glycerol is fairly simple, and the type of fatty acid and length is not identical;Fatty acid divides three categories: full
With fatty acid, monounsaturated fatty acids, polyunsaturated fatty acid;The source of fat can divide following two kinds: animality source: animal
The fat stored in vivo: such as lard, butter, sheep oil, fish oil, marrow, fat meat, cod-liver oil;Fat in animal cream: such as cream
Deng;Vegetalitas source: vegetablefats source is mainly extracted out of fruit in plant, such as sesame, sunflower seed, tea life, core
Peach, pine nut, soya bean etc.;It is compound by a variety of fatty acid, adjust saturated fatty acid, monounsaturated fatty acids, polyunsaturated fat
The content ratio of acid is that the ratio of 1:1:1, ω -6 and ω -3 are 10:1 ~ 2:1, preferably 5:1 ~ 2:1, preferred 2:1;It has been especially added with 2-
8 parts of omega-fatty acid, source include addition embedding material after the combination of one or both of fish oil, algae oil, are obtained through homogeneous
Then emulsion is obtained fatty powder using screening by being dried in spray drying device by emulsion;
Fat of the present invention refers to MCT powder, alpha-linolenic acid, linoleic acid, conjugated linoleic acid, corn oil, soybean oil, peanut
Oil, sunflower oil, olive oil, linseed oil, embryo oil are one such, several or whole mixes;
8. vitamin and mineral
Vitamin and mineral is nutrient needed by human, and the vitamin added in the present invention is that vitamin and mineral is people
Nutrient necessary to body;
The vitamin added in the present invention is vitamin A, vitamin D, vitamin E, vitamin K, vitamin K1, vitamin C, dimension
Raw element B1, vitamin B2, vitamin B6, vitamin B12, niacin, folic acid, pantothenic acid, choline, biotin it is therein several or all mixed
It closes;
The minerals added in the present invention are that calcium, phosphorus, potassium, sodium, magnesium, chlorine, iron, zinc, selenium, copper, manganese, iodine, fluorine, chromium, molybdenum are therein
Several or whole mixing, minerals of the present invention are added to the organic or inorganic compound of the minerals;
The vitamin and minerals mixture added in the present invention, be in strict accordance with equal increments method principle, specific blend technique into
The mixture that row is mixed to get.Mixing rate is 12-15r/min, incorporation time 20-40min;
9. the preparation method is that referring to Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), Cordyceps militaris, fructus alpiniae oxyphyllae, arillus longan, Noni fruit, wild jujube
Benevolence, dried orange peel, rhizoma polygonati, pueraria lobata, fructus lycii, peach kernel, phoenix peony, Poria cocos, purple perilla seed, nutmeg, emblic, hawthorn, field thistle,
Longstamen Onion Bulb, rhizoma imperatae, sea-buckthorn, eucommia Bark male flower, sanchi flower, Chinese yam, ginseng (artificial growth), 10 kinds therein of Saussurea involucrata culture or more
Or all by the way that cellulase, pectase, papain and amylase are added after the 60min-100min that is soaked in water, enzyme is used
1 mg/g substrate is measured, pH value is 4.0-5.0, in 50-80 DEG C of enzymatic hydrolysis 1-3h, solid-liquid ratio 1:15, with biological enzymolysis technology
After extracting Chinese medicine essence, extraction mixture that is spray-dried and being prepared into flour;The egg of biological enzymolysis extraction is added again
The sub- oil of white small peptide, prebiotics, amino acid, water-soluble dietary fiber, haematococcus pluvialis, MCT powder, alpha-linolenic acid, linoleic acid, conjugation
Acid carries out first time mixing, incorporation time 20-40min, mixing rate 30-45r/min;It is added again by stringent specific mixed
Technique: mixing rate 12-15r/min is closed, the multi-vitamins and minerals that incorporation time is 20-40min carry out Pasteur and go out
Bacterium 1 hour, Bifidobacterium after then adding microencapsulation was (bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, short
Bifidobacterium, bifidobacterium infantis, bifidobacterium longum), lactobacillus (lactobacillus acidophilus powder, Lactobacillus casei, bulgarian milk bar
Bacterium, Lactobacillus delbrueckii, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, Lactobacillus salivarius, Lactobacillus rhamnosus,
Lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus), streptococcus thermophilus and mix, incorporation time is
20-40min, mixing rate 30-45r/min obtain uniformly mixed powderous preparations technique.
The characteristic of this formula full nutrition formula food and its following aspects is mainly manifested in the effect of body:
1. the present invention is the requirement according to " special medicine purposes formula food general rule ", in conjunction with the constitutive character of patients with cerebral apoplexy,
The research achievements developments such as advanced physiology, medicine, nutrition and the clinical application of comprehensive nowadays American Harvard University, due to people
It is different, gold compatibility;
2. the marrow of the Traditional Chinese Medicine of present invention foundation " middle residence that disappears is mended ", " balanced tone " is theoretical, (liver,spleen,kidney three is dirty to be adjusted to together
Main principle), use the Chinese medical extract essence of a variety of dual-purpose of drug and food, a variety of probiotics, albumen small peptide for primary raw material, with prebiotic
Member, carbohydrate, amino acid, multivitamin and minerals be auxiliary material, the organic assembling of various ingredients, by various functions into
Row fusion, and pass through the synergistic effect between effective component, humidification effect;
3. there is effective absorbency, using inventive formulation, food of the various components using suitable ratio collocation preparation, warp
It is in isotonic state after a certain amount of water dissolution, small intestine can be reached quickly through stomach, absorbed quickly, completely, brain soldier can be supplemented rapidly
Nutrition needed for middle patient;
4. not only being mentioned using the extract of various dual-purpose of drug and food Chinese herbal medicines containing multiple functions active constituent in inventive formulation
The high concentration of function factor, reduces the intake of various impurity, helps to mitigate liver kidney burden, have enhancing resistance of human body
Effect there are also Bushen Yizhi, benefiting qi and nourishing blood, dissipating phlegm for resuscitation and improves efficacy of immunity;
5. probiotics contained in inventive formulation, a variety of probiotics can safeguard enteron aisle normal bacteria colony balance, inhibit disease
The growth of opportunistic pathogen prevents gastrointestinal disorders etc., and vitamin, amino acid are synthesized in enteron aisle and improves absorption of the body to calcium ion,
Enhance human immunologic function, prevent the side effect of antibiotic, improves host to the tolerance of radioactive ray, lactobacillus dramatically increases intestines
Mucosal immunity globulin A (SIgA) content has adjustment effect to body intestinal mucosa local immunity, adjusts stomach, intestines Tiny ecosystem, energy
The utilization rate of calcium, phosphorus, iron is improved, promotes the absorption of iron and vitamin D, the absorption of cholesterol can also be reduced;
6. inventive formulation food is using the food-borne bioactive short peptide in a variety of sources as nitrogen source, because small peptide is not required to digestion i.e.
It is absorbable, it is more advantageous to the utilization of body, patients with cerebral apoplexy negative nitrogen balance can be effectively improved, and food-borne small peptide can change
The structure and function of kind intestinal epithelial cell, improves the absorbability of intestinal mucosa;
7. prescription uses what this team was studied by being colonized the key technology of mechanism over nearly 3 years in enteron aisle to probiotics
Achievement improves " Chinese medicine of integration of drinking and medicinal herbs " compound that probiotics is colonized in enteron aisle, and the presence for combining prebiotics, which can be played, to be determined
The elements such as the enteron aisle adhesive capacity of plant effect, the reduction of intestinal pH environment and raising probiotic cell, therefore the food formula
Composition greatly strengthens the field planting effect to external source probio;
8. prebiotics contained in inventive formulation inhibit the growth of spoilage organisms by the growth and breeding of promotion enteral probiotics,
One of protective barrier is formed in intestinal mucosal surface simultaneously, damage of the enteron aisle spoilage organisms to intestinal mucosa can be resisted, reducing enteral has
The absorption of evil substance, can also promote intestines peristalsis, accelerate the discharge of enteral residuals, can prevent constipation, and pass through
Promote the growth and breeding of beneficial bacteria of intestinal tract that immunity of organisms also can be enhanced, small peptide, carbohydrate and active polysaccharide etc. are biological
Active material has synergistic effect;
9, carbohydrate contained in inventive formulation is that three kinds of main nutrients of thermal energy are provided for human body, in vivo
Can rapid oxidation energy is provided in time, avoid being used to valuable protein to provide energy, carbohydrate is also cell membrane
The important composition ingredient of glycoprotein, the glycolipid of nerve fiber and the DNA (DNA) to convey hereditary information, and carbon
The glycogen contained in hydrate, when it lays in abundance in liver, liver cell is to certain toxic chemical substances and various causes
The toxin that sick microorganism generates has stronger detoxification ability;
10, amino acid contained in inventive formulation is the basic unit for constituting protein, assigns the specific molecule knot of protein
It is configured state, makes it have biochemical activity, facilitates the metabolism of various sulfur-containing compounds in human body and the methyl contained by it is to having
Poisonous substance or drug are methylated and play the role of removing toxic substances, and muscle can be repaired, and control blood glucose, and provide energy to bodily tissue
Amount, also can be improved the absorption and utilization of food protein, reaches balanced nutritious;
11, inventive formulation food contains multivitamin and minerals, micronutrient needed for can supplementing rapidly patients with cerebral apoplexy
Element, small peptide is by further increasing the absorptivity of mineral matter element with after the chelating of calcium, iron, zinc etc.;
12, fatty in inventive formulation, maize germ oil, sunflower oil lack ω -3-PUFA rich in ω -6-PUFA;Olive
Oil, tea-seed oil are rich in monounsaturated fatty acids (MUFA), can increase rouge while supplementing protein, micronutrient
The intake of fat avoids the adverse effect of the high protein diets such as meat, egg.
Specific embodiment
Below by following embodiment, the invention will be further described, it will be helpful to understand the present invention;
Realize that the object of the invention cerebral apoplexy full nutrition formula food is the constitutive character to combine patients with cerebral apoplexy, according in tradition
The marrow of doctor is theoretical, varies with each individual, gold compatibility with the Chinese medical extract essence of 10 kinds or more dual-purpose of drug and food, a variety of probiotics,
Albumen small peptide is primary raw material, supplemented by prebiotics, carbohydrate, amino acid, fat, multivitamin, several mineral materials
Food made of expecting;Bifidobacterium is selected from bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, bifidobacterium breve, baby
Bifidobacterium, bifidobacterium longum one or more;Lactobacillus is selected from lactobacillus acidophilus powder, Lactobacillus casei, bulgarian milk
Bacillus, Lactobacillus delbrueckii, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, Lactobacillus salivarius, rhamnose cream bar
Bacterium, lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus one or more;Albumen small peptide is selected from sea
Foreign fish oligopeptide, dragon protein, sea bone peptide, Soyprotein peptide, whey protein peptide, ovalbumin peptide one or more;
Prebiotics are selected from oligoisomaltose, stachyose, oligofructose, the one or more of soyabean oligosaccharides, xylo-oligosaccharide;Amino acid
Selected from methionine, isoleucine, tyrosine, phenylalanine, lysine, arginine, histidine, tryptophan, citrulling, bird ammonia
Acid, taurine, γ-aminobutyric acid, the one or more of tealeaves theanine;Fat is selected from MCT powder, alpha-linolenic acid, linoleic acid, is total to
The one or more of conjugated linoleic acid, corn oil, soybean oil, peanut oil, sunflower oil, olive oil, linseed oil, embryo oil;Dimension
Raw element premix is selected from vitamin A, vitamin D, vitamin E, vitamin K1, vitamin C, vitamin B1, vitamin B2, dimension life
Plain B6, vitamin B12, niacin, folic acid, pantothenic acid, choline, one or more of biotin etc.;Mineral substance premix be selected from calcium,
One or more of phosphorus, potassium, sodium, magnesium, iron, zinc, selenium, copper, manganese, iodine, fluorine, chromium, molybdenum etc.;
Manufacturing process of the invention is with 10 kinds or more or whole integration of drinking and medicinal herbs raw materials are by being soaked in water after 60min-100min
Cellulase, pectase, papain and amylase, 1 mg/g substrate of enzyme dosage is added, pH value is 4.0-5.0,
50-80 DEG C of enzymatic hydrolysis 1-3h, solid-liquid ratio 1:15 through being spray-dried are prepared into pulverulent mixture after extracting Chinese medicine essence;It adds again
Albumen small peptide, the prebiotics, amino acid, water-soluble dietary fiber, haematococcus pluvialis, MCT powder, α-flax of biological enzymolysis extraction
Acid, linoleic acid, conjugated linoleic acid carry out first time mixing, incorporation time 20-40min, mixing rate 30-45r/min;Again
Stringent specific blend technique: mixing rate 12-15r/min is passed through in addition, and incorporation time is the multi-vitamins of 20-40min
And mixed after minerals progress pasteurization 1 hour with a variety of probiotics, incorporation time 20-40min, mixing rate is
30-45r/min obtains the preparation process of uniformly mixed powdery.
Embodiment one
Select following formula and ratio to be made and be mixed for cerebral apoplexy full nutrition formula food: by following raw materials according and its dosage into
Row formula: the extract of dual-purpose of drug and food: 15 parts of Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), 15 parts of Cordyceps militaris, 15 parts of fructus alpiniae oxyphyllae, arillus longan 15
Part, 15 parts of Noni fruit, 15 parts of semen ziziphi spinosae, 15 parts of dried orange peel, 15 parts of rhizoma polygonati, 15 parts of pueraria lobata, 15 parts of fructus lycii, 15 parts of peach kernel, phoenix
10 parts of peony, 10 parts of Poria cocos, 10 parts of purple perilla seed, 10 parts of nutmeg, 10 parts of emblic, 10 parts of hawthorn, 10 parts of field thistle, Longstamen Onion Bulb 10
Part, 10 parts of rhizoma imperatae, 10 parts of sea-buckthorn, 8 parts of eucommia Bark male flower, 8 parts of sanchi flower, 8 parts of Chinese yam, 5 parts of ginseng (artificial growth), saussurea involucrata training
Support 5 parts of object;75 parts of Bifidobacterium, 75 parts of lactobacillus, 40 parts of streptococcus thermophilus, 100 parts of L-Glutamine, 100 parts of albumen small peptide,
100 parts of prebiotics, 100 parts of water-soluble dietary fiber, 5 parts of haematococcus pluvialis, 150 parts of fatty powder, are answered at 100 parts of compound amino acid
Close 5 parts of vitamin, 50 parts of composite mineral matter;
When production first by Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), Cordyceps militaris, fructus alpiniae oxyphyllae, arillus longan, Noni fruit, semen ziziphi spinosae, dried orange peel, rhizoma polygonati,
Pueraria lobata, fructus lycii, peach kernel, phoenix peony, Poria cocos, purple perilla seed, nutmeg, emblic, hawthorn, field thistle, Longstamen Onion Bulb, rhizoma imperatae,
Sea-buckthorn, eucommia Bark male flower, sanchi flower, Chinese yam, ginseng (artificial growth), Saussurea involucrata culture are soaked in water after 60min and cellulose are added
Enzyme, pectase, papain and amylase, 1 mg/g substrate of enzyme dosage, pH value are 4.0, in 50 DEG C of enzymatic hydrolysis 3h, material
Liquor ratio 1:15 through being spray-dried is prepared into pulverulent mixture after extracting Chinese medicine essence;
Secondly addition biological enzymolysis extract albumen small peptide, prebiotics, amino acid, water-soluble dietary fiber, haematococcus pluvialis,
MCT powder, alpha-linolenic acid, linoleic acid, conjugated linoleic acid carry out first time mixing, incorporation time 20min, mixing rate 45r/
min;
Stringent specific blend technique: mixing rate 12r/min is passed through in addition again, and the compound dimension that incorporation time is 40min is raw
Carries out pasteurization 1 hour after element and minerals mixing, then a variety of Bifidobacteriums after addition microencapsulation, lactobacillus, thermophilic
Hot streptococcus simultaneously mixes incorporation time as 40min, and mixing rate 30r/min obtains the preparation process of uniformly mixed powdery;
Embodiment two
Above-mentioned cerebral apoplexy full nutrition formula food is also an option that following formula and ratio are made and is mixed for cerebral apoplexy and seeks entirely
Support formula food: the extract of dual-purpose of drug and food: 18 parts of Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), 18 parts of Cordyceps militaris, 18 parts of fructus alpiniae oxyphyllae, arillus longan
18 parts, 18 parts of Noni fruit, 18 parts of semen ziziphi spinosae, 18 parts of dried orange peel, 18 parts of rhizoma polygonati, 18 parts of pueraria lobata, 15 parts of fructus lycii, 15 parts of peach kernel, pellet
15 parts of phoenix peony, 12 parts of Poria cocos, 12 parts of purple perilla seed, 10 parts of nutmeg, 10 parts of emblic, 10 parts of hawthorn, 8 parts of field thistle, Longstamen Onion Bulb 8
Part, 8 parts of rhizoma imperatae, 8 parts of sea-buckthorn, 5 parts of eucommia Bark male flower, 5 parts of sanchi flower, 5 parts of Chinese yam, 5 parts of ginseng (artificial growth), saussurea involucrata culture
5 parts of object;85 parts of Bifidobacterium, 55 parts of lactobacillus, 50 parts of streptococcus thermophilus, 100 parts of L-Glutamine, 100 parts of albumen small peptide, benefit
It is raw 100 parts of member, 100 parts of compound amino acid, 100 parts of water-soluble dietary fiber, 150 parts of fatty powder, 5 parts of multi-vitamins, compound
50 parts of minerals;
When production first by Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), Cordyceps militaris, fructus alpiniae oxyphyllae, arillus longan, Noni fruit, semen ziziphi spinosae, dried orange peel, rhizoma polygonati,
Pueraria lobata, fructus lycii, peach kernel, phoenix peony, Poria cocos, purple perilla seed, nutmeg, emblic, hawthorn, field thistle, Longstamen Onion Bulb, rhizoma imperatae,
Sea-buckthorn, eucommia Bark male flower, sanchi flower, Chinese yam, ginseng (artificial growth), Saussurea involucrata culture are soaked in water after 80min and cellulose are added
Enzyme, pectase, papain and amylase, 1 mg/g substrate of enzyme dosage, pH value are 4.5, in 60 DEG C of enzymatic hydrolysis 2h, material
Liquor ratio 1:15 through being spray-dried is prepared into pulverulent mixture after extracting Chinese medicine essence;
Secondly addition biological enzymolysis extract albumen small peptide, prebiotics, amino acid, water-soluble dietary fiber, haematococcus pluvialis,
MCT powder, alpha-linolenic acid, linoleic acid, conjugated linoleic acid carry out first time mixing, incorporation time 30min, mixing rate 35r/
min;
Stringent specific blend technique: mixing rate 15r/min is passed through in addition again, and the compound dimension that incorporation time is 20min is raw
Carries out pasteurization 1 hour after element and minerals mixing, then a variety of Bifidobacteriums after addition microencapsulation, lactobacillus, thermophilic
Hot streptococcus simultaneously mixes incorporation time as 30min, and mixing rate 35r/min obtains the preparation process of uniformly mixed powdery;
Embodiment three
Above-mentioned cerebral apoplexy full nutrition formula food is also an option that following formula and ratio are made and is mixed for cerebral apoplexy and seeks entirely
Support formula food: the extract of dual-purpose of drug and food: 18 parts of Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), 18 parts of Cordyceps militaris, 18 parts of fructus alpiniae oxyphyllae, arillus longan
18 parts, 18 parts of Noni fruit, 18 parts of semen ziziphi spinosae, 18 parts of dried orange peel, 18 parts of rhizoma polygonati, 18 parts of pueraria lobata, 15 parts of fructus lycii, 15 parts of peach kernel, pellet
15 parts of phoenix peony, 12 parts of Poria cocos, 12 parts of purple perilla seed, 10 parts of nutmeg, 10 parts of emblic, 8 parts of field thistle, 8 parts of Longstamen Onion Bulb, rhizoma imperatae
8 parts, 8 parts of sea-buckthorn, 5 parts of eucommia Bark male flower, 5 parts of sanchi flower, 5 parts of Chinese yam, 5 parts of Saussurea involucrata culture;75 parts of Bifidobacterium, lactobacillus 65
Part, 50 parts of streptococcus thermophilus, 100 parts of L-Glutamine, 100 parts of albumen small peptide, 100 parts of prebiotics, 100 parts of compound amino acid,
100 parts of water-soluble dietary fiber, 150 parts of fatty powder, 5 parts of multi-vitamins, 50 parts of composite mineral matter;
When production first by Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), Cordyceps militaris, fructus alpiniae oxyphyllae, arillus longan, Noni fruit, semen ziziphi spinosae, dried orange peel, rhizoma polygonati,
Pueraria lobata, fructus lycii, peach kernel, phoenix peony, Poria cocos, purple perilla seed, nutmeg, emblic, hawthorn, field thistle, Longstamen Onion Bulb, rhizoma imperatae,
Sea-buckthorn, eucommia Bark male flower, sanchi flower, Chinese yam, ginseng (artificial growth), Saussurea involucrata culture are soaked in water after 100min and cellulose are added
Enzyme, pectase, papain and amylase, 1 mg/g substrate of enzyme dosage, pH value are 5.0, in 80 DEG C of enzymatic hydrolysis 1h, material
Liquor ratio 1:15 through being spray-dried is prepared into pulverulent mixture after extracting Chinese medicine essence;
Secondly addition biological enzymolysis extract albumen small peptide, prebiotics, amino acid, water-soluble dietary fiber, haematococcus pluvialis,
MCT powder, alpha-linolenic acid, linoleic acid, conjugated linoleic acid carry out first time mixing, incorporation time 40min, mixing rate 30r/
min;
Stringent specific blend technique: mixing rate 13r/min is passed through in addition again, and the compound dimension that incorporation time is 30min is raw
Carries out pasteurization 1 hour after element and minerals mixing, then a variety of Bifidobacteriums after addition microencapsulation, lactobacillus, thermophilic
Hot streptococcus simultaneously mixes incorporation time as 20min, and mixing rate 40r/min obtains the preparation process of uniformly mixed powdery.
Claims (3)
1. a kind of edible specific full nutritional formulas of patients with cerebral apoplexy, it is characterised in that its material composition content includes with weight
The following component of meter: integration of drinking and medicinal herbs ingredient: 10-20 parts of Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), 10-20 parts of Cordyceps militaris, fructus alpiniae oxyphyllae 10-20
Part, 10-20 parts of arillus longan, 10-20 parts of Noni fruit, 10-20 parts of semen ziziphi spinosae, 10-20 parts of dried orange peel, 10-20 parts of rhizoma polygonati, pueraria lobata 10-
20 parts, 10-20 parts of fructus lycii, 10-20 parts of peach kernel, 8-15 parts of phoenix peony, 8-15 parts of Poria cocos, 8-15 parts of purple perilla seed, Pork and beans
8-15 parts cool, 8-15 parts of emblic, 8-15 parts of hawthorn, 8-15 parts of field thistle, 5-10 parts of Longstamen Onion Bulb, 5-10 parts of rhizoma imperatae, sea-buckthorn 5-10
Part, 5-10 parts of eucommia Bark male flower, 5-10 parts of sanchi flower, 5-10 parts of Chinese yam, 5-10 parts of ginseng (artificial growth), Saussurea involucrata culture 5-10
Part;A variety of probiotics: 50-100 parts of Bifidobacterium (bifidobacterium adolescentis, bifidobacterium lactis, not tally bifid bar after microencapsulation
Bacterium, bifidobacterium breve, bifidobacterium infantis, bifidobacterium longum), 50-100 parts of lactobacillus (lactobacillus acidophilus powder, cheese cream bar
Bacterium, lactobacillus bulgaricus, Lactobacillus delbrueckii, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, saliva cream bar
Bacterium, Lactobacillus rhamnosus, lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus), streptococcus thermophilus
20-60 parts, 50-150 parts of L-Glutamine, 50-150 parts of albumen small peptide (dragon protein, ocean fish oligopeptide, sea bone peptide,
Soybean protein, whey protein peptide, ovalbumin peptide), 50-150 parts of prebiotics (oligoisomaltose, stachyose, oligofructose,
Soyabean oligosaccharides, xylo-oligosaccharide), 50-150 parts of compound amino acid (methionine, isoleucine, tyrosine, phenylalanine, rely ammonia
Acid, arginine, histidine, tryptophan, citrulling, ornithine, taurine, γ-aminobutyric acid, tealeaves theanine), water-soluble meals
Food fiber 50-150 parts, 5-10 parts of haematococcus pluvialis, 100-200 parts of fatty powder (MCT powder, alpha-linolenic acid, linoleic acid, corn oil,
Soybean oil, peanut oil, sunflower oil, olive oil, linseed oil, embryo oil, conjugated linoleic acid), vitamin premix (vitamin
A, vitamin D, vitamin E, vitamin K1, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacin, leaf
Acid, pantothenic acid, choline, biotin) 5 parts;Mineral substance premix (calcium, phosphorus, potassium, sodium, magnesium, iron, zinc, selenium, copper, manganese, iodine, fluorine, chromium,
Molybdenum) 50 parts.
2. a kind of edible specific full nutritional formulas of patients with cerebral apoplexy according to claim 1, which is characterized in that first
By Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), Cordyceps militaris, fructus alpiniae oxyphyllae, arillus longan, Noni fruit, semen ziziphi spinosae, dried orange peel, rhizoma polygonati, pueraria lobata, fructus lycii,
Peach kernel, phoenix peony, Poria cocos, purple perilla seed, nutmeg, emblic, hawthorn, field thistle, Longstamen Onion Bulb, rhizoma imperatae, sea-buckthorn, Cortex Eucommiae are male
Flower, sanchi flower, Chinese yam, ginseng (artificial growth), Saussurea involucrata culture are by being added cellulose after the 60min-100min that is soaked in water
Enzyme, pectase, papain and amylase, 1 mg/g substrate of enzyme dosage, pH value is 4.0-5.0, at 50-80 DEG C
1-3h, solid-liquid ratio 1:15 are digested, through being spray-dried is prepared into pulverulent mixture after extracting Chinese medicine essence;Biological enzymolysis is added again
The albumen small peptide of extraction, prebiotics, amino acid, water-soluble dietary fiber, haematococcus pluvialis, MCT powder, alpha-linolenic acid, linoleic acid,
Conjugated linoleic acid carries out first time mixing, incorporation time 20-40min, mixing rate 30-45r/min;It is added again by tight
Lattice specific blend technique: mixing rate 12-15r/min, incorporation time be 20-40min multi-vitamins and minerals into
It is mixed after row pasteurization 1 hour with a variety of probiotics, incorporation time 20-40min, mixing rate 30-45r/
Min obtains the preparation process of uniformly mixed powdery.
3. a kind of edible specific full nutritional formulas of patients with cerebral apoplexy according to claim 1, which is characterized in that institute
The integration of drinking and medicinal herbs ingredient stated includes following component: Gynura divaricata (Radix et Rhizoma Gynurae divaricatae), Cordyceps militaris, fructus alpiniae oxyphyllae, arillus longan, Noni fruit, acid
It is jujube kernel, dried orange peel, rhizoma polygonati, pueraria lobata, fructus lycii, peach kernel, phoenix peony, Poria cocos, purple perilla seed, nutmeg, emblic, hawthorn, small
Ji, Longstamen Onion Bulb, rhizoma imperatae, sea-buckthorn, eucommia Bark male flower, sanchi flower, Chinese yam, ginseng (artificial growth), 10 kinds therein of Saussurea involucrata culture
Above or all;
A variety of probiotics include following component: streptococcus thermophilus, Bifidobacterium, lactobacillus;Wherein, Bifidobacterium refers to
Bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, bifidobacterium breve, bifidobacterium infantis, bifidobacterium longum wherein one
Kind, several or all mixing;Lactobacillus refers to lactobacillus acidophilus powder, Lactobacillus casei, lactobacillus bulgaricus, De Shi cream bar
Bacterium, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, Lactobacillus salivarius, Lactobacillus rhamnosus, Luo Yishi cream bar
Bacterium, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus are one of, several or whole mixes;
The albumen small peptide refer to ocean fish oligopeptide, dragon protein, sea bone peptide, soybean protein, whey protein peptide, ovum
Ovalbumin peptide is one of, several or whole mixes;
The prebiotics refer to oligoisomaltose, stachyose, oligofructose, soyabean oligosaccharides, xylo-oligosaccharide therein one
Kind, several or all mixing;
The compound amino acid refers to L-Glutamine, methionine, isoleucine, tyrosine, phenylalanine, lysine, essence
Propylhomoserin, histidine, tryptophan, citrulling, ornithine, taurine, γ-aminobutyric acid, tealeaves theanine are one such, several
Or all mixing;
The fatty powder refers to MCT powder, alpha-linolenic acid, linoleic acid, conjugated linoleic acid, corn oil, soybean oil, peanut oil, certain herbaceous plants with big flowers
Flower seed oil, olive oil, linseed oil, embryo oil are one such, several or whole mixes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810883264.4A CN108936628A (en) | 2018-08-06 | 2018-08-06 | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810883264.4A CN108936628A (en) | 2018-08-06 | 2018-08-06 | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108936628A true CN108936628A (en) | 2018-12-07 |
Family
ID=64467421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810883264.4A Pending CN108936628A (en) | 2018-08-06 | 2018-08-06 | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108936628A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109730309A (en) * | 2019-01-10 | 2019-05-10 | 蕴彤本草(北京)生物科技有限公司 | Brain tonic and intelligence development tranquilizing the mind relieves stress fructus alpiniae oxyphyllae complex polypeptide nutrition element and preparation method |
CN109965274A (en) * | 2019-04-28 | 2019-07-05 | 巩雪 | A kind of remodeling brain structure neuron feature promotes mental training method |
CN113750134A (en) * | 2020-06-01 | 2021-12-07 | 深圳市领治医学科技有限公司 | Traditional Chinese medicine microecological preparation for patients with ischemic stroke |
CN114766670A (en) * | 2022-05-18 | 2022-07-22 | 王民珏 | Special dietary food formula with sleep-aiding function |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107319550A (en) * | 2017-06-22 | 2017-11-07 | 劲膳美食品股份有限公司 | Brain trauma full nutrition formula food |
-
2018
- 2018-08-06 CN CN201810883264.4A patent/CN108936628A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107319550A (en) * | 2017-06-22 | 2017-11-07 | 劲膳美食品股份有限公司 | Brain trauma full nutrition formula food |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109730309A (en) * | 2019-01-10 | 2019-05-10 | 蕴彤本草(北京)生物科技有限公司 | Brain tonic and intelligence development tranquilizing the mind relieves stress fructus alpiniae oxyphyllae complex polypeptide nutrition element and preparation method |
CN109965274A (en) * | 2019-04-28 | 2019-07-05 | 巩雪 | A kind of remodeling brain structure neuron feature promotes mental training method |
CN113750134A (en) * | 2020-06-01 | 2021-12-07 | 深圳市领治医学科技有限公司 | Traditional Chinese medicine microecological preparation for patients with ischemic stroke |
CN114766670A (en) * | 2022-05-18 | 2022-07-22 | 王民珏 | Special dietary food formula with sleep-aiding function |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105341906A (en) | Medical formula food for diabetes | |
CN104187611A (en) | Total nutrient formula food for gastrointestinal malabsorption | |
CN104187708A (en) | Total-nutrient formulated food for patients with diabetes | |
CN104839680A (en) | Medical formula food for people with cardiovascular diseases | |
CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
CN104996994A (en) | Chronic obstructive pulmonary disease specific full nutritional formula food | |
CN104172191A (en) | Total-nutrition formula food for treating atherosclerosis | |
CN108968037A (en) | Senile dementia full nutrition formula food | |
CN104839684A (en) | Medical formula food for people with helicobacter pylori related gastritis | |
CN104839656A (en) | Liver disease medicine formula food | |
CN105029393A (en) | Medical formula food for children | |
CN105380263A (en) | Full-nutrition formula food for treating pregnant woman constipation | |
CN107319550A (en) | Brain trauma full nutrition formula food | |
CN104839655A (en) | High blood lipids, blood sugar and blood pressure lowering and yang tonifying medical formula food | |
CN107334156A (en) | Lactagogue full nutrition formula food | |
CN104839678A (en) | Medical formula food for people with nephrosis | |
CN105029400A (en) | Medical formula food for rheumatoid arthritis | |
CN104187637A (en) | Full-nutritional formula food for tonifying Yang | |
CN104146254A (en) | Full-nutrition formulated food for hypertension | |
CN108936607A (en) | Chronic Obstructive Pulmonary Disease full nutrition formula food | |
CN104839673A (en) | Medical formula food for people with renal failure | |
CN104839670A (en) | Specific endowment constitution medical formula food | |
CN104839676A (en) | Medical formula food for people with gastrointestinal tract absorption obstacle | |
CN104187721A (en) | Total nutrient formula food for cardiovascular diseases | |
CN104256656A (en) | Full-nutrition formulated food for fatty acid metabolic disorder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 321100 Yuezhong Road, Lanjiang Street, Lanxi City, Jinhua City, Zhejiang Province Applicant after: Zhejiang yongbaokang'an Medical Technology Co., Ltd Address before: 321112 No. 21, Yuezhong Road, Lanjiang street, Lanxi City, Jinhua City, Zhejiang Province Applicant before: LANXI YONGBAO KANGAN NUTRITIONAL FOOD Co.,Ltd. |
|
CB02 | Change of applicant information | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181207 |
|
WD01 | Invention patent application deemed withdrawn after publication |